Locally Advanced Hepatocellular Carcinoma

DrugDrug NameDrug Description
DB09035NivolumabA PD-1 blocking antibody used to treat melanoma, non small-cell lung cancer, renal cell cancer, head and neck cancer, and Hodgkin lymphoma.
DrugDrug NamePhaseStatusCount
DB11595Atezolizumab1Not Yet Recruiting1
DB08875Cabozantinib1Completed1
DB00531Cyclophosphamide1Recruiting1
DB11714Durvalumab1Recruiting1
DB09035Nivolumab1Completed1
DB09037Pembrolizumab1Recruiting1
DB00020Sargramostim1Recruiting1
DB11771Tremelimumab1Recruiting1
DB11595Atezolizumab2Not Yet Recruiting1
DB11595Atezolizumab2Recruiting2
DB11595Atezolizumab2Withdrawn1
DB00112Bevacizumab2Not Yet Recruiting1
DB00112Bevacizumab2Recruiting1
DB08875Cabozantinib2Recruiting1
DB08875Cabozantinib2Withdrawn1
DB06186Ipilimumab2Recruiting1
DB09078Lenvatinib2Recruiting1
DB09035Nivolumab2Recruiting1